Observational Study of Endothelial Dysfunction in Phenylketonuria
NCT02176603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2017-02-23
Summary
The purpose of this study is to determine whether adolescent and adult patients with phenylketonuria who are on long-term phenylalanine-restricted diet suffer from endothelial dysfunction.
Conditions
- Phenylketonuria
- Endothelial Dysfunction
Sponsors & Collaborators
-
Johannes Gutenberg University Mainz
collaborator OTHER -
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Julia B Hennermann, MD · Johannes Gutenberg University Mainz, Germany
-
Uwe Querfeld, MD · Charite University, Berlin, Germany
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2015-07-22
- Completion
- 2017-01-01
More Related Trials
-
Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects
NCT06687733 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of NGGT002 in PKU Adult Subjects
NCT06061614 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia
NCT03167697 ·Status: COMPLETED ·Phase: NA
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
NCT06332807 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Testing of Four Home Phenylalanine Monitoring Prototype Devices
NCT02445521 ·Status: COMPLETED
-
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT06628128 ·Status: RECRUITING ·Phase: PHASE3
-
Natural History Clinical Study in Adult PKU
NCT04768348 ·Status: TERMINATED
-
SNAP: Study Nutrients in Adult PKU
NCT03858101 ·Status: COMPLETED
-
Evaluation of Low Phenylalanine Formulas
NCT06332105 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
NCT00841100 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
NCT04256655 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
NCT06629987 ·Status: COMPLETED
-
Liver Cell Transplant for Phenylketonuria
NCT01465100 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency
NCT05050669 ·Status: COMPLETED
-
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
NCT05827536 ·Status: TERMINATED ·Phase: NA
-
Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
NCT01924026 ·Status: COMPLETED
-
PANDA: PKU Amino Acid Evaluation
NCT04086511 ·Status: COMPLETED
-
Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety
NCT00432822 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study of BH4, a New and Simple Treatment of Mild PKU
NCT00260000 ·Status: COMPLETED ·Phase: PHASE2
-
Phenylketonuria, Oxidative Stress, and BH4
NCT01395394 ·Status: TERMINATED ·Phase: PHASE2
-
Gene Therapy Clinical Study in Adult PKU
NCT03952156 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
NCT02014883 ·Status: COMPLETED ·Phase: PHASE2